Theraclion SA (EPA:ALTHE)

Theraclion Statistics

Total Valuation

Theraclion has a market cap or net worth of EUR 30.16 million. The enterprise value is 33.58 million.

Market Cap	30.16M
Enterprise Value	33.58M

Important Dates

The last earnings date was Thursday, April 16, 2026.

Earnings Date	Apr 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Theraclion has 58.01 million shares outstanding.

Current Share Class	58.01M
Shares Outstanding	58.01M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.16%
Owned by Institutions (%)	5.61%
Float	35.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.01
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.90
EV / Sales	14.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-41.39

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.21%
Revenue Per Employee	72,469
Profits Per Employee	-177,813
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-837,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +250.14% in the last 52 weeks. The beta is 0.18, so Theraclion's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	+250.14%
50-Day Moving Average	0.53
200-Day Moving Average	0.62
Relative Strength Index (RSI)	52.62
Average Volume (20 Days)	35,243

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theraclion had revenue of EUR 2.32 million and -5.69 million in losses.

Revenue	2.32M
Gross Profit	2.24M
Operating Income	-6.37M
Pretax Income	-6.53M
Net Income	-5.69M
EBITDA	-6.05M
EBIT	-6.37M
Earnings Per Share (EPS)	n/a

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	321,394
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 96.51%, with operating and profit margins of -274.86% and -245.36%.

Gross Margin	96.51%
Operating Margin	-274.86%
Pretax Margin	-281.46%
Profit Margin	-245.36%
EBITDA Margin	-261.00%
EBIT Margin	-274.86%
FCF Margin	n/a

Dividends & Yields

Theraclion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-18.86%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1